Table 1.
Demographic data, IBD treatments, and anemia profiles of the patients in the study.
| CrD | UC | p | |
|---|---|---|---|
| Gender (female/male) (n) | 151/212 | 183/213 | 0.263∗ |
| Mean age (years) (SD) | 45.9 (±14) | 47.5 (±16.1) | 0.157∗∗ |
| Mean duration of disease (years) (SD) | 6.42 (±5.7) | 8.29 (±6.8) | <0.001∗∗ |
| Mean hemoglobin (g/dL) (SD) (13.5–17.5) | 11.9 (±2.2) | 12.2 (±2.2) | 0.026∗∗ |
| Mean ferritin (ng/mL) (SD) (23.9–336.2) | 51 (±86.7) | 36 (±59.7) | 0.001∗∗ |
| Mean transferrin saturation (%) (SD) (15–50) | 12.8 (±11.5) | 11.9 (10.1) | 0.318∗∗ |
| Received treatment for anemia (n, %) | 151 (41.59%) | 148 (37.37%) | 0.255∗ |
| Did not use NSAID (n) (%) | 48 (13.22%) | 8 (2.02%) | <0.001∗ |
| Used NSAID (n) (%) | 315 (86.77%) | 388 (97.97%) | |
| Used steroids (n) (%) | 258 (71.07%) | 193 (48.73%) | <0.001∗ |
| Used immunomodulatory agents (n) (%) | 256 (70.52%) | 122 (30.80%) | <0.001∗ |
| Used biologic agents (n) (%) | 107 (29.47%) | 28 (7.07%) | <0.001∗ |
∗Chi-squared test; ∗∗Mann–Whitney U test. CrD: Chron's disease; UC: ulcerative colitis; SD: standard deviation; NSAID: nonsteroidal anti-inflammatory drug; g/dL: gram per decilitre; ng/mL: nanogram per millilitre.